POLYTHÉRAPIE À BASE D'UN ANTICORPS ANTI-CD20 AFUCOSYLÉ ET D'UN CONJUGUÉ ANTICORPS ANTI-CD79B

• 收藏
• 分享

专利权人:

F. Hoffmann-La Roche AG

发明人:

申请号：

EP14724662.3

公开号：

EP2992016B1

申请日:

2014.04.30

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with a CD79b antibody-drug conjugate for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody and a CD79b antibody-drug conjugate.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/